Toggle light / dark theme

This #COVID19 is quite weird it just keeps evolving. In a weird way it is pushing evolution through our immune system. The only thing I know that is similar is like the flu or a bigger organism like cancer. Based on this information the virus just keeps evolving not dying off. Among the weird stuff it doesn’t effect cats or most animals or plants. Basically we either need a universal vaccine which is still being developed or we may need quantum radar to kill off the virus in our bodies when it comes out either that or foglet armor to not breathe it in like Ironman. I find it is just an odd virus as essentially it evolves so fast past even human beings abilities to fend it off even with suits it seems to spread so fast that it cannot be completely contained. From dogs that sniff it out it seems sorta everywhere. I know minor things like high dosages of vitamin c work with zinc and probiotics which was the first way to battle it when it didn’t become this whole pandemic because oddly enough it wasn’t a big deal in previous years because the 19th version of the virus. I know some things that kill it off are ultra violet and lysol as well as bleach. So it makes me think it is more a bioweapon where the universal vaccine would work. But oddly enough I am uncertain if it really dies off especially if it is airborne. If we can destroy the virus by reprogramming it to be sterile or innert or even for it to just kill itself off with crispr like we have done with mosquitoes to stop malaria. We can easily make new vaccines which is good but nearly every year or so there is an entirely new version. This isn’t new but it sorta is like the flu. But there are some theories that I sorta have where it seems to be near heat sources where it grows. Like my uncle who had the virus which we had him turn off electricity and also do vitamin c probiotics and zinc which did work. He ended up getting an antibody naturally this way. I personally got the vaccine and found that it does work but when the new delta version came out it did the same as the last one it sorta just randomly evolves for some reason even smells similar but oddly enough it still remains even after all the lysol. So to me it seems like a bioweapon that is self evolving which is we could use the mechanism to essentially evolve ourselves taking the components of it. If this was a nanobot swarm I would say it spreads from radio waves or something but this virus keeps spreading in odd ways like even from the sky. Which sorta makes me believe that it is sorta being manipulated maybe by a signal perhaps or it has its own program inside it. It reminds me of a Grey goo nanobot swarm that keeps evolving but the biological virus version. I mean it could actually be an exterrestial virus there was a meteorite that came around then and odd things that followed from the meteorite like dogs attacking people and cats attacking people even huge mountain lions. Which makes me think of a sorta an invasion of something. We need to maybe get the viruses input and output to find what it is going to do next. All and all seems odd because even other viruses don’t evolve or like fly or spread that fast. Ideally we should have cyborg nanobots running through Ironman in avengers endgame but so far our best better is treating it like the flu pumping out a new vaccine each year till we know a universal vaccine like using henreitta lacks immortal unlimited cell division cells like they did with polio. But till then we need to keep watching the virus as seems sorta more than it appears based on its original version.


See allHide authors and affiliations.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

The field of neuroprosthetics was around in its earliest stage in the 1950s, but it’s only just starting to show its true potential, with devices that allow amputees to feel and manipulate their surroundings.

A group of researchers from MIT and Shanghai Jiao Tong University, recently collaborated with the goal of making neuroprosthetic hands, which allow users to feel in a more accessible way. The result is an inflatable robotic hand that costs only $500 to build, making it much cheaper than comparable devices, a post from MIT reveals.

The researchers behind the new prosthetic say their device bears an uncanny resemblance to the inflatable robot in the animated film Big Hero 6. The prosthetic uses a pneumatic system to inflate and bend the fingers of the device, allowing its user to grasp objects, pour a drink, shake hands, and even pet a cat if they so wish. It allows all of this via a software program — detailed in the team’s paper in the journal Nature Biomedical Engineering — that “decodes” EMG signals the brain is sending to an injured or missing limb.

Bionic arms used to cost $80,000. Now, a young engineer has lowered the cost by over 90%.

Subscribe here: https://freeth.ink/youtube-subscribe-toc.

Unlimited Tomorrow is pioneering a new age in prosthetics with its 3D-printed robotic arms. Founded in 2,014 by Easton LaChapelle when he was just 18 years old, the company is poised to become a leader in the prosthetic arm industry. Their True Limb device costs less than $8,000 and it’s even cheaper for children, priced at about $4,000.

True Limb is both functional and realistic-looking, serving as a mirror image of the amputee’s opposing limb, even down to the fingertips. And while the prosthetic arm is 60–90% cheaper than traditional prosthetics, many users say it’s far superior to market alternatives. What’s the secret? Unlimited Tomorrow uses a totally remote, custom process that cuts out middlemen to produce prosthetics completely in-house.

For the 40-million worldwide amputees in need of prosthetic limbs, this remote, personalized, and affordable process for fitting prosthetics means hope for a better future.

See the full article on bionic arms here: https://www.freethink.com/series/challengers/prosthetic-arm.

VLADIVOSTOK, Russia — To see Russia’s ambitions for its own version of Silicon Valley, head about 5,600 miles east of Moscow, snake through Vladivostok’s hills and then cross a bridge from the mainland to Russky Island. It’s here — a beachhead on the Pacific Rim — that the Kremlin hopes to create a hub for robotics and artificial intelligence innovation with the goal of boosting Russia’s ability to compete with the United States and Asia.


On Russia’s Pacific shores, the Kremlin is trying to build a beachhead among the Asian tech powers.

Every dad should do this. 😃


French dad and robotics engineer Jean-Louis Constanza has built a robotic suit for his 16-year-old son Oscar that allows him to walk.

Oscar, a wheelchair user, activates the suit by saying “Robot, stand up” and it then walks for him.

Jean-Louis co-founded the company that builds the suit, which can allow users to move upright for a few hours a day.

It is used in several hospitals, but it isn’t yet available for everyday use by individuals and has a price tag of around €150000 (about £127700).

But while science fiction provides military planners with a tantalizing glimpse of future weaponry, from exoskeletons to mind-machine interfaces, the genre is always about more than flashy new gadgets. It’s about anticipating the unforeseen ways in which these technologies could affect humans and society – and this extra context is often overlooked by the officials deciding which technologies to invest in for future conflicts.

Imagined worlds

Like my colleague David Seed, who has studied how fiction impacts on real-life threat assumptions about nuclear terrorism, I’m interested in how science fiction informs our sense of the future. This has given me the opportunity to work with members of the armed forces, using science fiction to query assumptions and generate novel visions of the future.

Original Article from The New England Journal of Medicine — Neuroprosthesis for Decoding Speech in a Paralyzed Person with Anarthria.


Dr. Moses, Mr. Metzger, and Ms. Liu contributed equally to this article.

A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.

We thank the study participant “Bravo-1” for his dedication and commitment; the members of Karunesh Ganguly’s laboratory for help with the clinical study; Mark Chevillet, Emily Mugler, Ruben Sethi, and Stephanie Thacker for support and feedback; Nick Halper and Kian Torab for hardware technical support; Mariann Ward for clinical nursing support; Matthew Leonard, Heather Dawes, and Ilona Garner for feedback on an earlier version of the manuscript; Viv Her for administrative support; Kenneth Probst for illustrating an earlier version of Figure 1; Todd Dubnicoff for video editing; and the participant’s caregivers for logistic support.